Koortslipcrème Aciclovir Da (Aciclovir)

Aciclovir is a nucleoside analogue that, once inside infected cells, is converted to its active triphosphate form. This active form inhibits the viral DNA polymerase enzyme, blocking viral DNA synthesis and replication, thereby limiting the spread of the herpes simplex virus in the treated area.

The specific dosing regimen for Koortslipcrème Aciclovir Da is determined by the prescribing clinician. Typically, the cream is applied to the affected area several times daily for a limited period, but exact frequency and duration should follow the healthcare provider’s instructions.

Safety data for topical aciclovir during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using this product.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Koortslipcrème Aciclovir Da offers a topical formulation of aciclovir, providing direct delivery to lesions with minimal systemic exposure. Compared with oral antivirals, it is useful for localized infections and may have fewer systemic side effects, though oral therapy may be preferred for extensive or severe disease.

Store the cream at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Ensure the tube is tightly closed after each use to maintain product stability.

The cream should be applied to clean, dry skin over the affected area, usually 5 mm beyond the visible lesion. It is typically used several times a day as directed by a healthcare professional, and hands should be washed before and after application.

Serious risks, though rare, include allergic reactions such as contact dermatitis, angioedema, or severe skin irritation. If signs of an allergic response or worsening skin condition occur, discontinue use and seek medical attention promptly.

Individuals with a known hypersensitivity to aciclovir or any component of the cream should avoid its use. Additionally, patients with extensive skin damage, severe immunosuppression, or those advised against topical antivirals by their physician should not use this product.